Physician profile
Clive Williams
NPI 1083262075
$1,865.24
in general payments reported to CMS, 2019-2025
15 companies · $374 in 2025
The $374 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $150 · 2022: $164 · 2023: $533 · 2024: $645 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,551.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $297.62 | 2023-2024 | Quviviq |
| Novo Nordisk INC | $277.39 | 2022-2024 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $157.83 | 2023-2024 | Farxiga, Airsupra |
| Abbvie INC. | $156.75 | 2021-2023 | |
| Braeburn INC. | $152.84 | 2025 | Brixadi |
| Phathom Pharmaceuticals, INC. | $151.46 | 2024 | Voquezna |
| Inspire Medical Systems, INC. | $113.42 | 2023 | Inspire |
| Gilead Sciences, INC. | $107.48 | 2024 | |
| Glaxosmithkline, LLC. | $101.14 | 2025 | Nucala |
| Kyowa Kirin, INC. | $86.67 | 2025 | |
| Biogen, INC. | $76.99 | 2022 | |
| Genentech USA, INC. | $76.63 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $75.60 | 2023 | Dupixent |
| Urgo Medical North America, LLC | $17.42 | 2025 | Urgoclean Ag |
| Indivior INC. | $16.00 | 2025 | Sublocade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clive Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.